{
    "xml": "<topic id=\"PHP8249\" outputclass=\"drug\" rev=\"1.26\" type=\"drug\" namespace=\"/drugs/bacillus-calmette-gurin-vaccine\" basename=\"bacillus-calmette-gurin-vaccine\" title=\"BACILLUS CALMETTE-GU&#201;RIN VACCINE\">\n<title>BACILLUS CALMETTE-GU&#201;RIN VACCINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1317\" namespace=\"/interactions/list-of-drug-interactions/vaccines/bcg-vaccine\">BCG Vaccine</xref>\n</p>\n<data name=\"vtmid\">420538001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_581448509\" title=\"Vaccines\">Vaccines</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34568\" title=\"VACCINES\" namespace=\"/drug-classes/vaccines\">VACCINES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">BCG Vaccine</p>\r\n</body>\n<topic id=\"PHP35640\" outputclass=\"drugAction\" rev=\"1.14\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>BCG (Bacillus Calmette-Gu&#233;rin) is a live attenuated strain derived from <ph outputclass=\"organism\">\n<i>Mycobacterium bovis</i>\n</ph> which stimulates the development of immunity to <ph outputclass=\"organism\">\n<i>M. tuberculosis</i>\n</ph>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35622\" outputclass=\"indicationsAndDose\" rev=\"1.33\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Immunisation against tuberculosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intradermal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 months</p>\n<p>0.05&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;17 years</p>\n<p>0.1&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.1&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35651\" outputclass=\"contraindications\" rev=\"1.15\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Generalised septic skin conditions</ph>; <ph outputclass=\"contraindication\">neonate in household contact with known or suspected case of active tuberculosis</ph> (in neonates)</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Contra-indications, further information</title>\n<sectiondiv>\n<p>A lesion-free site should be used to administer BCG vaccine to patients with eczema.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35857\" outputclass=\"cautions\" rev=\"1.11\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>BCG vaccine can be given simultaneously with another live vaccine, but if they are not given at the same time an interval of 4 weeks should normally be allowed. When BCG is given to infants, there is no need to delay routine primary immunisations. No further vaccination should be given in the arm used for BCG vaccination for at least 3 months because of the risk of regional lymphadenitis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35580\" outputclass=\"sideEffects\" rev=\"1.13\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Disseminated complications</ph>; <ph outputclass=\"sideEffect\">osteitis</ph>; <ph outputclass=\"sideEffect\">osteomyelitis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Prolonged ulceration at the injection site</ph>; <ph outputclass=\"sideEffect\">subcutaneous abscess at the injection site</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35588\" outputclass=\"preTreatmentScreening\" rev=\"1.11\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Pre-treatment screening</title>\n<body>\r\n<section>\r\n<sectiondiv>\r\n<p>Apart from children under 6 years, any person being considered for BCG immunisation must first be given a skin test for hypersensitivity to tuberculoprotein (see <xref format=\"dita\" href=\"#PHP34509\" type=\"drug\" namespace=\"/drugs/tuberculin-purified-protein-derivative\">tuberculin purified protein derivative</xref>). A skin test is not necessary for a child under 6 years provided that the child has not stayed for longer than 3 months in a country with an incidence of tuberculosis greater than 40 per 100 000, the child has not had contact with a person with tuberculosis, and there is no family history of tuberculosis within the last 5 years.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP35864\" outputclass=\"directionsForAdministration\" rev=\"1.17\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Intradermal injection technique</p>\n<p>Skin is stretched between thumb and forefinger and needle (size 25G or 26G) inserted (bevel upwards) for about 3&#8239;mm into superficial layers of dermis (almost parallel with surface). Needle should be short with short bevel (can usually be seen through epidermis during insertion). Tense raised blanched bleb showing tips of hair follicles is sign of correct injection; 7&#8239;mm bleb &#8801; 0.1&#8239;mL injection, 3&#8239;mm bleb &#8801; 0.05&#8239;mL injection; if considerable resistance not felt, needle too deep and should be removed and reinserted before giving more vaccine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61861\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.14\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Prescribing and dispensing information</title>\n<body>\r\n<section>\r\n<sectiondiv>\r\n<p>Available from health organisations or direct from ImmForm<xref format=\"html\" href=\"https://www.immform.dh.gov.uk\">www.immform.dh.gov.uk</xref>(SSI brand, multidose vial with diluent).</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP8249-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/bacillus-calmette-gurin-vaccine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75108\" title=\"Powder and solvent for suspension for injection\" namespace=\"/drugs/bacillus-calmette-gurin-vaccine/powder-and-solvent-for-suspension-for-injection\">Powder and solvent for suspension for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78335\" namespace=\"/treatment-summaries/vaccines\" title=\"Vaccines\" count=\"3\" rel=\"backlink\">Vaccines</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1317\" namespace=\"/interactions/list-of-drug-interactions/vaccines/bcg-vaccine\" title=\"BCG Vaccine\" count=\"1\" rel=\"link\">BCG Vaccine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34568\" namespace=\"/drug-classes/vaccines\" title=\"VACCINES\" count=\"1\" rel=\"link\">VACCINES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP34509\" namespace=\"/drugs/tuberculin-purified-protein-derivative\" title=\"TUBERCULIN PURIFIED PROTEIN DERIVATIVE\" count=\"1\" rel=\"link\">TUBERCULIN PURIFIED PROTEIN DERIVATIVE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75108\" namespace=\"/drugs/bacillus-calmette-gurin-vaccine/powder-and-solvent-for-suspension-for-injection\" title=\"Powder and solvent for suspension for injection\" count=\"1\" rel=\"link\">Powder and solvent for suspension for injection</xref>\n</links>\n</topic>",
    "id": "PHP8249",
    "outputclass": "drug",
    "rev": "1.26",
    "type": "drug",
    "namespace": "/drugs/bacillus-calmette-gurin-vaccine",
    "basename": "bacillus-calmette-gurin-vaccine",
    "title": "BACILLUS CALMETTE-GUÃ‰RIN VACCINE",
    "interactants": [
        {
            "id": "bnf_int_1317",
            "label": "BCG Vaccine"
        }
    ],
    "vtmid": "420538001",
    "drugClassification": [
        "Vaccines"
    ],
    "inheritsFromClass": [
        "VACCINES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "BCG Vaccine"
    ],
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "BCG (Bacillus Calmette-Gu&#233;rin) is a live attenuated strain derived from Mycobacterium bovis which stimulates the development of immunity to M. tuberculosis .",
                "html": "<p>BCG (Bacillus Calmette-Gu&#233;rin) is a live attenuated strain derived from <ph outputclass=\"organism\">\n<i>Mycobacterium bovis</i>\n</ph> which stimulates the development of immunity to <ph outputclass=\"organism\">\n<i>M. tuberculosis</i>\n</ph>.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Immunisation against tuberculosis",
                        "html": "Immunisation against tuberculosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intradermal injection"
                    ],
                    "textContent": "By intradermal injection",
                    "html": "By intradermal injection"
                },
                "child": [
                    {
                        "textContent": "0.05 mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be avoided.",
                        "html": "<p>0.05&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>",
                        "ageGroup": "1&#8211;11 months"
                    },
                    {
                        "textContent": "0.1 mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be avoided.",
                        "html": "<p>0.1&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>",
                        "ageGroup": "1&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "0.1 mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be avoided.",
                        "html": "<p>0.1&#8239;mL, to be injected at insertion of deltoid muscle onto humerus (keloid formation more likely with sites higher on arm); tip of shoulder should be <b>avoided</b>.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Generalised septic skin conditions",
                "html": "Generalised septic skin conditions"
            },
            {
                "type": "contraindications",
                "textContent": "neonate in household contact with known or suspected case of active tuberculosis in neonates",
                "html": "neonate in household contact with known or suspected case of active tuberculosis in neonates",
                "specificity": {
                    "patientType": "neonates"
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "A lesion-free site should be used to administer BCG vaccine to patients with eczema.",
                "html": "<p>A lesion-free site should be used to administer BCG vaccine to patients with eczema.</p>"
            }
        ]
    },
    "cautions": {
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "BCG vaccine can be given simultaneously with another live vaccine, but if they are not given at the same time an interval of 4 weeks should normally be allowed. When BCG is given to infants, there is no need to delay routine primary immunisations. No further vaccination should be given in the arm used for BCG vaccination for at least 3 months because of the risk of regional lymphadenitis.",
                "html": "<p>BCG vaccine can be given simultaneously with another live vaccine, but if they are not given at the same time an interval of 4 weeks should normally be allowed. When BCG is given to infants, there is no need to delay routine primary immunisations. No further vaccination should be given in the arm used for BCG vaccination for at least 3 months because of the risk of regional lymphadenitis.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Disseminated complications",
                        "html": "Disseminated complications",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "osteitis",
                        "html": "osteitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "osteomyelitis",
                        "html": "osteomyelitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Prolonged ulceration at the injection site",
                        "html": "Prolonged ulceration at the injection site",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "subcutaneous abscess at the injection site",
                        "html": "subcutaneous abscess at the injection site",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "preTreatmentScreening": {
        "preTreatmentScreening": [
            {
                "type": "preTreatmentScreening",
                "references": [
                    {
                        "id": "PHP34509",
                        "label": "tuberculin purified protein derivative"
                    }
                ],
                "textContent": "Apart from children under 6 years, any person being considered for BCG immunisation must first be given a skin test for hypersensitivity to tuberculoprotein (see tuberculin purified protein derivative). A skin test is not necessary for a child under 6 years provided that the child has not stayed for longer than 3 months in a country with an incidence of tuberculosis greater than 40 per 100 000, the child has not had contact with a person with tuberculosis, and there is no family history of tuberculosis within the last 5 years.",
                "html": "<p>Apart from children under 6 years, any person being considered for BCG immunisation must first be given a skin test for hypersensitivity to tuberculoprotein (see <xref format=\"dita\" href=\"#PHP34509\" type=\"drug\" namespace=\"/drugs/tuberculin-purified-protein-derivative\">tuberculin purified protein derivative</xref>). A skin test is not necessary for a child under 6 years provided that the child has not stayed for longer than 3 months in a country with an incidence of tuberculosis greater than 40 per 100 000, the child has not had contact with a person with tuberculosis, and there is no family history of tuberculosis within the last 5 years.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "title": "Intradermal injection technique",
                "textContent": "Skin is stretched between thumb and forefinger and needle (size 25G or 26G) inserted (bevel upwards) for about 3 mm into superficial layers of dermis (almost parallel with surface). Needle should be short with short bevel (can usually be seen through epidermis during insertion). Tense raised blanched bleb showing tips of hair follicles is sign of correct injection; 7 mm bleb &#8801; 0.1 mL injection, 3 mm bleb &#8801; 0.05 mL injection; if considerable resistance not felt, needle too deep and should be removed and reinserted before giving more vaccine.",
                "html": "<p>Skin is stretched between thumb and forefinger and needle (size 25G or 26G) inserted (bevel upwards) for about 3&#8239;mm into superficial layers of dermis (almost parallel with surface). Needle should be short with short bevel (can usually be seen through epidermis during insertion). Tense raised blanched bleb showing tips of hair follicles is sign of correct injection; 7&#8239;mm bleb &#8801; 0.1&#8239;mL injection, 3&#8239;mm bleb &#8801; 0.05&#8239;mL injection; if considerable resistance not felt, needle too deep and should be removed and reinserted before giving more vaccine.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "references": [
                    {
                        "id": "https://www.immform.dh.gov.uk",
                        "label": "www.immform.dh.gov.uk"
                    }
                ],
                "textContent": "Available from health organisations or direct from ImmFormwww.immform.dh.gov.uk(SSI brand, multidose vial with diluent).",
                "html": "<p>Available from health organisations or direct from ImmForm<xref format=\"html\" href=\"https://www.immform.dh.gov.uk\">www.immform.dh.gov.uk</xref>(SSI brand, multidose vial with diluent).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75108",
                "label": "Powder and solvent for suspension for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78335",
                "label": "Vaccines",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1317",
                "label": "BCG Vaccine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34568",
                "label": "VACCINES",
                "type": "drugClass"
            }
        ],
        "drug": [
            {
                "id": "PHP34509",
                "label": "TUBERCULIN PURIFIED PROTEIN DERIVATIVE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75108",
                "label": "Powder and solvent for suspension for injection",
                "type": "medicinalForm"
            }
        ]
    }
}